Transcriptional and neurochemical signatures of cerebral blood flow alterations in schizophrenia and individuals at clinical high-risk for psychosis

Sam Knight, Leyla Abbasova, Yashar Zeighami, Justine Hansen, Daniel Martins, Fernando Zelaya, Ottavia Dipasquale, Thomas Liu, David Shin, Matthijs Bossong, Matilda Azis, Mathilde Antoniades, Oliver Howes, Ilaria Bonoldi, Alice Egerton, Paul Allen, Owen O'Daly, Philip McGuire, Gemma Modinos

Research output: Contribution to journalArticlepeer-review

11 Downloads (Pure)

Abstract

Background
The brain integrates multiple scales of description, from the level of cells and molecules to large-scale networks and behaviour. Understanding relationships across these scales may be fundamental to advancing understanding of brain function in health and disease. Recent neuroimaging research has shown that functional brain alterations that are associated with schizophrenia spectrum disorders (SSD) are already present in young adults at clinical high-risk for psychosis (CHR-P), yet the cellular and molecular determinants of these alterations remain unclear.

Methods
Here, we used regional cerebral blood flow (rCBF) data from 425 individuals (122 SSD compared to 116 HCs, and 129 CHR-P compared to 58 HCs) and applied a novel pipeline to integrate brain-wide rCBF case-control maps with publicly available transcriptomic data (17,205 gene maps) and neurotransmitter atlases (19 maps) from 1074 healthy volunteers.

Results
We identified significant correlations between astrocyte, oligodendrocyte precursor cell, and vascular leptomeningeal cell gene modules for both SSD and CHR-P rCBF phenotypes, and additionally microglia and oligodendrocytes in CHR-P. Receptor distribution significantly predicted case-control rCBF differences, with dominance analysis highlighting dopamine (D1, D2, DAT), acetylcholine (VAChT, M1), GABAA, and NMDA receptors as key predictors for SSD (R2adj=.58, PFDR<.05) and CHR-P (R2adj=.6, PFDR<.05) rCBF phenotypes. These associations were primarily localised in subcortical regions and implicate cell-types involved in stress response and inflammation, alongside specific neuroreceptor systems, in shared and distinct rCBF phenotypes in psychosis.

Conclusions
Our findings underscore the value of integrating multi-scale data as a promising hypothesis-generating approach towards decoding biological pathways involved in neuroimaging-based psychosis phenotypes, potentially guiding novel interventions.
Original languageEnglish
JournalBiological psychiatry
Publication statusAccepted/In press - 3 Feb 2025

Keywords

  • schizophrenia
  • arterial spin labelling
  • neuroimaging
  • gene expression
  • neurotransmitters
  • mental health
  • biomarkers

Fingerprint

Dive into the research topics of 'Transcriptional and neurochemical signatures of cerebral blood flow alterations in schizophrenia and individuals at clinical high-risk for psychosis'. Together they form a unique fingerprint.

Cite this